Tag: Ovarian cancer lawyer

Talcum Powder Lawyers Win | Talc Lawsuit Alert

Talcum Powder Lawyers Win For Ovarian Cancer Victim

J&J  Has Been Ordered to Pay $417 Million

(Reuters) – A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company’s talc-based products like Johnson’s Baby Powder for feminine hygiene.
The Los Angeles Superior Court jury’s verdict in favor of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of its talc-based products.
“We are grateful for the jury’s verdict on this matter and that Eva Echeverria was able to have her day in court,” Mark Robinson, her lawyer, said in a statement.
The verdict included $70 million in compensatory damages and $347 million in punitive damages. It was a major setback for J&J, which faces 4,800 similar claims nationally and has been hit with over $300 million in verdicts by juries in Missouri.
“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” J&J said.
Echeverria’s lawsuit was the first out of hundreds of California talc cases to go to trial.
The 63-year-old claimed she developed terminal ovarian cancer after decades of using J&J’s products. Her lawyers argued J&J encouraged women to use its products despite knowing of studies linking ovarian cancer to genital talc use.
J&J’s lawyers countered that studies and federal agencies have not found that talc products are carcinogenic.
The trial follows five prior ones in Missouri state court, where many lawsuits are pending.
J&J lost four of those trials and, along with a talc supplier, has been hit with $307 million in verdicts. Before Monday, the largest verdict was for $110 million.
The Missouri cases, which have largely been brought by out-of-state plaintiffs, have faced jurisdictional questions after the U.S. Supreme Court issued a ruling in June that limited where personal injury lawsuits can be filed.
In a decision in a case involving Bristol-Myers Squibb Co, the Supreme Court said state courts cannot hear claims against companies that are not based in the state when the alleged injuries did not occur there.
The ruling prompted a St. Louis judge, at New Jersey-based J&J’s urging, to declare a mistrial in the talc case already underway.
The judge has nonetheless left the door open for the plaintiffs to argue they still have jurisdiction based on a Missouri-based bottler J&J used to package its products.
The case is Echeverria et al v. Johnson & Johnson, Los Angeles Superior Court, No. BC628228.
(Reporting by Nate Raymond in Boston; Editing by Matthew Lewis and Paul Simao)

If you or a loved one used  Johnson and Johnson Talcum Powder  products for over five years on or near the genital area and now have a diagnosis of ovarian cancer or fallopian tube cancer contact The Talcum Powder Lawyer Helpline today.

Talcum Powder Cancer Lawsuits Continue

Johnson and Johnson Facing Potentially  1000’s Of Ovarian Cancer Lawsuits

Johnson and Johnson won a  fourth talcum powder lawsuit but, had  three judgements of $72 million, $70 million and $55 million. Our lawyers have filed dozens of talcum powder lawsuits  on behalf of women who claim they got  ovarian cancer from Johnson & Johnson’s talcum based powders. A fifth talcum baby powder lawsuit was heard in the 22nd Circuit Court in St. Louis, Missouri, on April 10th. The jury heard the case of Lois Slemp, who alleges that she developed ovarian cancer as a result of long term use of talc powder found in feminine hygiene products made by Johnson & Johnson (J&J).

A California state court judge will convene a 5-day “Sargon” hearing, California’s equivalent of a Daubert proceeding, to determine the admissibility of expert witness testimony. This could be as significant as a trial itself, after a New Jersey state court judge in October nixed testimony from two key expert witnesses for the plaintiff, scuttling what was set to the first talcum powder trial in the state. That decision remains on appeal.

Depending on the outcome of the June hearing, a bellwether trial is scheduled for July in Los Angeles, along with another trial scheduled that same month in Washington D.C. Superior Court. .

The case is captioned Valerie Swann, et al. v. Johnson & Johnson, et al. case number 1422 CC09326-01 in Missouri’s 22nd Judicial Circuit Court.

Talcum powder cases continue in Federal court. About 134 cases are on file in the District of New Jersey Federal Court. The parties have been discussing various topics, including a protective order, a preservation order and other legal issues. A preservation order is where a plaintiff has to store physical or biological evidence for use in trials.

Johnson & Johnson reported in a recent filing with the U.S. Securities & Exchange Commission (SEC) that it has been named a defendant in at least 3,100 product liability claims. These lawsuits are claims by women that Baby Powder and Shower-to-Shower talc-based powders contributed to them getting ovarian cancer.

If you think you have a diagnosis of ovarian cancer due to your use of Baby Powder or Shower To Shower contact us today

 

Woman Wins Big On Talcum Powder Ovarian Cancer Claim

A Jury Granted More Than $70M In A J&J Baby Powder  Ovarian Cancer Lawsuit.

A California woman has been awarded more than $70 million  in a claim that Johnson and Johnson’s baby powder gave  her ovarian cancer.

“We are pleased the jury did the right thing. They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product,” Jim Onder, an attorney for the plaintiff, advised The Associated Press.

“We deeply sympathize with the women and families impacted by ovarian cancer,” Carol Goodrich, a spokeswoman with Johnson & Johnson, said in a statement. “We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”

Is Baby Powder Safe?

It is now known that use of talc products can  increase a women’s risk of ovarian cancer.

The International Agency for Research on Cancer advises that the product is “possibly carcinogenic.” The National Toxicology Program, made up of parts of a few distinctive government organizations, has not completely inspected talc.

 

 

What Is Talc?

Talcum Powder Lawsuit Helpline is always seeking articles we believe will be of interest to our readers.  Talcum Powder  products causing ovarian cancer have resulted in an onslaught of lawsuits across the country. Talcum Powder is made from Talc. But, what exactly is Talc?
Talc is a hydrous magnesium silicate mineral with a chemical composition of Mg3Si4O10(OH)2. If you are not a chemist you probably have no idea what that means. In lay terms, Talcum powder is made from talc. Talc is a mineral made up of  magnesium, silicon, and oxygen. Talc is usually green, white, gray, brown, or colorless. It is a translucent mineral with a pearly luster.

About Talc In the US

The United States is self-sufficient for most types of talc used in manufacturing. Estimated 2011 production was 615,000 metric tons with a value of about $20 million. Three companies in the United States account for nearly 100% of the country’s production.

How Does Talc Form?
Talc is a mineral that is most often found in the metamorphic rocks of convergent plate boundaries. It forms from at least two processes. Most large talc deposits in the United States formed when heated waters carrying dissolved magnesium and silica reacted with dolomitic marbles. A second process of talc formation occurred when heat and chemically active fluids altered rocks such as dunite and serpentinite into talc.
Talc Mining In The US
Most talc in the United States is produced from an open pit mine where the rock is drilled, blasted, and partially crushed in the mining operation. The highest grade ores are produced by selective mining and sorting operations.

Great care is taken during the mining process to avoid contaminating the talc with other rock materials. These other materials can have an adverse effect on the color of the product. Contamination can introduce hard particles that cause problems in applications where talc is being used because of its softness or lubricating properties.

Partially crushed rock is taken from the mine to a mill, where it is further reduced in particle size. Impurities are sometimes removed by froth flotation or mechanical processing. The mills produce crushed or finely ground talc that meets customer requirements for particle size, brightness, composition, and other properties.
Uses of Talc: Talc is used as a filler, coating, pigment, dusting agent and extender in plastics, ceramics, paint, paper, cosmetics, roofing, rubber and many other products.

Talc Information

U.S. Talc — Baby Powder and Much More: U.S. Geological Survey, Fact Sheet FS-065-00, September 2000.

Talc in Cosmetics: United States Food and Drug Administration, website article, last accessed August 2016.

Use Of Talc in Cosmetics and Antiperspirants
Finely ground talc is used as the powder base of many cosmetic products. The tiny platelets of a talc powder readily adhere to the skin but can be washed off easily. Talc’s softness allows it to be applied and removed without causing skin abrasion.

Talc also has the ability to absorb oils and perspiration produced by human skin. The ability of talc to absorb moisture, absorb odor, adhere to the skin, serve as a lubricant, and produce an astringent effect in contact with human skin make it an important ingredient in many antiperspirants. In 2011, about 7% of the talc consumed in the United States was used to make cosmetics and antiperspirant.

Talc and asbestos occur naturally and may occur in close proximity in some metamorphic rocks. Studies published in the 1960s and 1970s identified health concerns about the use of talc that contains asbestos in some cosmetic products.

According to the FDA, “These studies have not conclusively demonstrated such a link, or if such a link existed, what risk factors might be involved.” To address these concerns, talc mining sites are now carefully selected and ores are carefully processed to avoid the presence of asbestos in talc destined for use in the cosmetics industry.

Talc used in Talcum powder has been associated with the development of ovarian cancer due to inflammation

 

 

Alternatives To Talcum Powder

Talcum Powder Lawsuit Helpline continues to get calls on a daily basis from women with a diagnosis of ovarian cancer seeking a Talcum Powder lawyer. The Talcum Powder Lawsuit Helpline offers the latest news on Talcum Powder and the Talc Lawsuits. We found this article online about alternatives to talcum powder and think it will be helpful to our readers.

What Are The Alternatives To Talcum Powder?

Not all medical professionals agree that a link between baby powder and ovarian cancer exists.
The recent headlines about baby powder and its connection to ovarian cancer may raise more questions than answers. In February, a Missouri court ordered Johnson & Johnson to pay $72 million in damages to the family of Jackie Fox, a woman who died of ovarian cancer. The lawsuit said her death was linked to her 50-year daily habit of applying baby powder. But Johnson & Johnson insisted a correlation between talc powder and ovarian cancer has not been proven.

“The verdict goes against decades of sound science proving the safety of talc as a cosmetic ingredient in multiple products, and while we sympathize with the family of the plaintiff, we strongly disagree with the outcome,” a spokesman for the company said in a statement.

Prosecutors say Johnson & Johnson knew about the risk since the early 1980s and did not protect its customers. In fact, the first study conducted on talc powder use on female genitalia found a 92 percent increased risk for ovarian cancer with women who reported genital talc use. But still, other doctors disagree. “Several decades of medical research do not support the hypothesis that use of talcum powder causes ovarian cancer,” said Dr. Hal Lawrence, chief executive officer of the American Congress of Obstetricians and Gynecologists.

If all this back-and-forth has you questioning your baby powder usage, fear not. There are some safe alternatives to talc powder:

Cornstarch. Found in the baking aisle of your local grocery store, cornstarch is a great natural alternative to talc. The consistency is exactly the same, so it’ll help soak up wetness just as well. Cornstarch is derived from the endosperm of a corn kernel and is often used to help thicken sauces.

Arrowroot starch or tapioca starch. Both staples in a paleo baker’s kitchen, these starches are all-natural alternatives to talc. Arrowroot is derived from several tropical South American plants. Tapioca starch is derived from the crushed-up pulp of the South American cassava plant, a woody shrub. Both are used in paleo recipes as alternatives to flour and cornstarch. If you’re using it to on your baby’s sore bottom, try this recipe with some extra ingredients to help soothe.

Baking soda. You thought sodium bicarbonate, otherwise known as baking soda, only had 100 uses. Well, here’s one more: This common pantry item can be used in place of baby powder. Some people even use it as deodorant, applying some to their underarms each morning. It can also deodorize the air. As a matter of fact, I keep one container in my pantry, one under my sink, one in my laundry room and one in the bathroom.

Oat flour. Try this if you’re looking for a slightly coarser powder than the ones mentioned above.

Commercial baby powder alternatives. These products combine the items listed above with essential oils, so the powder smells pretty nice. Just to name a few:

Burt’s Bee’s Baby Dusting Powder
Honeybee Gardens Deodorant Powder
The Honest Company Organic Baby Powder
Nature’s Baby Dusting Powder
Here’s one last reason to consider the all-natural route: Talc is poisonous when inhaled or swallowed. It can cause breathing problems, which is why the American Academy of Pediatrics urges caution when it comes to using talc powder on babies.

If you or a loved one has a diagnosis of ovarian cancer and you or they have used Talcum Powder to dry off around the genital areas for over five years it would be in your best interest to call the Talcum Powder Lawsuit Helpline and speak to one of our talcum powder lawyers

Rio Tinto Mining Company Added To Talcum Powder Lawsuits

The Talcum Powder Lawsuit Helpline keeps you updated on all the latest news relating to  the Talcum Powder Lawsuits. We all know that Johnson and Johnson is the manufacturer or Johnson’s Baby Powder and Shower to Shower and that lawsuits are being filed against them for ovarian cancer from the use of their Talcum Powder products. But, where do they get the talc from? Is it the responsibility of the mining company to warn as well?

In a recent talcum powder lawsuit Rio Tinto is now being sued for talcum powder sourced from their mines causing ovarian cancer.

Johnson & Johnson is the owner of Rio Tinto Minerals Inc. Yes, more Johnson and Johnson but, now we are getting to the source as the lawsuits go even deeper into the negligence.  The Louisiana lawsuit has been filed  by four women with cancer and the husband of a woman who died from ovarian cancer.

This is the fist lawsuit to include the mining company Rio Tinto. Rio Tinto Minerals’ subsidiary at the time Luzenac America is also named in the case as having mined the “talc at issue” which was used to manufacture Johnson’s Baby Powder and Shower to Shower.
The lawsuits for after all three companies for “failing  to inform its customers and end users of its products of a known catastrophic health hazard associated with the use of its products”.

“All of the defendants have been aware for nearly forty years of independent scientific studies linking the use of their products to the increased risk of ovarian cancer in women when used in the perineal area,” the documents state.

“Luzenac America Inc and Rio Tinto Minerals Inc supply customers with materials safety data sheets for talc.”

“These material safety data sheets are supposed to convey adequate health and warning information.”

This is a major new step in the ovarian cancer- Talcum Powder litigation and means a much deeper pocket for victims to tap into. We may be looking at the largest mass tort ever.

 

 

FDA Approves New Ovarian Cancer Drug

The Talcum Powder Lawsuit Helpline has qualified Baby Powder and Shower To Shower lawyers for women who feel their ovarian cancer diagnosis is due to ” dusting Off ” for years with talcum powder products.  The Talcum Powder Lawsuit Helpline continues to keep woman and families updated on the talcum Powder Lawsuit latest news and any new research or news pertaining to ovarian cancer that we think will be helpful to our readers.

We found this  online and feel it is important information for our readers.

FRIDAY, Dec. 19, 2014 (HealthDay News) — The U.S. Food and Drug Administration has approved a new drug to treat advanced ovarian cancer, along with a test to identify patients eligible to receive the drug.

Lynparza (olaparib) belongs to a new class of drugs called poly ADP-ribose polymerase (PARP) inhibitors. The drug is for women who have already received extensive treatment for advanced ovarian cancer associated with defective BRCA genes, according to an FDA news release issued Friday.

“Today’s approval constitutes the first of a new class of drugs for treating ovarian cancer,” Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research, said in the news release.

“Lynparza is approved for patients with specific abnormalities in the BRCA gene and is an example of how a greater understanding of the underlying mechanisms of disease can lead to targeted, more personalized treatment,” he said.

Approval of the AstraZeneca drug was based on a clinical trial of almost 140 women with BRCA mutation-associated ovarian cancer. Thirty-four percent of the patients on the drug had partial shrinkage or complete disappearance of their tumors for an average of eight months, the FDA reported.

Nausea, fatigue, vomiting, diarrhea, headache, decreased appetite, joint and muscle pain, and cold-like symptoms were common side effects of the drug. More serious side effects included lung inflammation; the bone marrow cancer acute myeloid leukemia; and myelodysplastic syndrome, a condition where the bone marrow is unable to produce enough functioning blood cells, the FDA said.

Women must undergo a genetic test to confirm BRCA gene mutations before they can be treated with Lynparza. The test to confirm those genes was approved by the FDA in conjunction with the drug.

BRCA genes play a role in repairing damaged DNA. Normally, they work to suppress tumor growth. Women with mutations that cause defective BRCA genes have an increased risk for ovarian and breast cancer. It’s believed that 10 to 15 percent of all ovarian cancer is associated with these mutations, the FDA said.

In 2014, nearly 22,000 American women will be diagnosed with ovarian cancer and more than 14,000 will die from the disease, according to the U.S. National Cancer Institute.

If you or a loved one has a diagnosis of ovarian cancer and has used talcum powder products for years contact the Talcum Powder Lawsuit Helpline.

Liquid Biopsies For Earlier Ovarian Cancer Tracking

The Talcum Powder Lawsuit Helpline continues in one of  it’s missions  to offer the latest news regarding ovarian cancer. We receive dozens of calls on a daily basis from women who feel their use of Talcum Powder products has resulted in their ovarian cancer diagnosis. We continue to connect women with qualified talcum powder ovarian cancer lawyers and offer news we feel will be helpful to these women.

We found this latest news online and hope it will be helpful to our followers.

There is new news about  liquid biopsies offering  hope for earlier treatment and  better tracking of ovarian cancer.

A promising new way to monitor and treat recurrence of ovarian cancer has been identified by researchers a hard-to-detect disease that claims many lives. New research finds liquid biopsies from blood tests and DNA sequencing can detect a return of ovarian cancer long before a tumor reappears.

If you have used Talcum Powder products and suspect an ovarian cancer this may be an option to check out with your doctor.

Researchers at the Mayo Clinic Center for Individualized Medicine have found a promising new way to monitor and treat recurrence of ovarian cancer — a hard-to-detect disease that claims many lives. New research from George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, finds liquid biopsies from blood tests and DNA sequencing can detect a return of ovarian cancer long before a tumor reappears. That could lead to earlier intervention and more effective, individualized treatment. Dr. Vasmatzis’ research on the “Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-free DNA From Ovarian Cancers” is published in the July 20 edition of Scientific Reports.

“With liquid biopsies, we don’t have to wait for tumor growth to get a DNA sample,” says Dr. Vasmatzis. “This important discovery makes it possible for us detect recurrence of the disease earlier than other diagnostic methods. We can repeat liquid biopsies to monitor the progression of the cancer. That gives hope of a better treatment plan over time.”

The study was done on 10 patients in advanced stages of ovarian cancer. Blood was drawn before and after surgery. Investigators compared DNA from the liquid blood biopsies to DNA tissue samples from the tumor, using mate-pair sequencing — an inexpensive whole exome sequencing that can reveal genetic changes that contribute to tumor growth.

“In this study, the blood drawn before and after surgery and the surgical tissue was used to identify DNA fragments with abnormal junctions that can only be seen in this patient’s tumor DNA,” explains Dr. Vasmatzis. “Next-generation mate-pair sequencing was used to identify specific DNA changes of the tumor to create an individualized monitoring panel for liquid biopsy. This allows us to shape treatment to the individual patient rather than using a standard treatment that may not work for everyone.”

When post-surgery DNA matched that of the tumor, patients were later found to have had a recurrence of ovarian cancer. However, when the post-surgery DNA did not match the DNA of the tumor, patients were found to be in remission.

Ovarian cancer has one of the highest death rates of all gynecological cancers, because the tumor often cannot be detected until the late stages. Most patients go into remission after initial treatment, but the tumor returns 75 percent of the time. The next stage of ovarian cancer that develops typically does not respond to chemotherapy. More than 21,000 women in the U.S. were diagnosed with ovarian cancer, and 14,000 women died of the disease in 2015.

We wonder if the 1000’s of women using talcum powder products and the latest research on the link between talcum powder use and ovarian cancer has anything to do with such huge numbers. Many women have used talcum powder for years, especially in the Afro American and Hispanic community. J & J marketed their products to these women and the idea of smelling fresh and clean became a girlfriend to girlfriend positive  in smelling  “sweet and fresh like  Talcum Powder today.”

Talcum Powder Lawsuits Headed For Consolidation- MDL Status

It looks like the Talcum Powder lawsuits will be consolidated in a multi District litigation. A Multi District Litigation results in  all the ovarian cancer  lawsuits under one judge in one jurisdiction. The Talcum Powder Lawsuit Helpline continues to keep you updated on the progress of the Talcum Powder Lawsuits.
There have been more than 1,200 talcum powder ovarian cancer lawsuits  filed against Johnson & Johnson in state and federal courts.

A talcum powder lawsuit motion has been filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) seeking  to  consolidate  all  ovarian cancer lawsuits  in a single court, under one judge  in order to coordinate pretrial proceedings and make the process easier.  The chosen venue  suggested is the  U.S. District Court, Southern District of Illinois.

The motion claims  that the current ovarian cancer  plaintiffs reside in several different states and that the Southern District of Illinois would permit convenient travel for the parties and counsel.

Talcum Powder Lawsuit Helpline is reaching out to women who were diagnosed with ovarian cancer following years of regular, repeated use of talcum powder  products for feminine hygiene purposes.

Talcum Powder Ovarian Cancer Lawsuits

All of the talcum powder lawsuits have one thing in common. They claim that regular repeated and long term use  of Johnson & Johnson’s Baby Powder and Shower-to-Shower products to the genital area  can increase a woman’s risk of being  diagnosed with  ovarian cancer. All the lawsuits  claim  that talc particles can make their way into the vagina and migrate to the ovaries.  The accumulation of talc particles and the constant irritation and inflammation  can promote the growth of cancer cells. A number of studies published since the 1970s have suggested  a link.   Johnson & Johnson has failed to take any steps to warn women of this possible risk and link between Talc products and ovarian cancer.

More than 1,200 talcum powder lawsuits have been filed against Johnson & Johnson nationwide.   In April, a St. Louis jury awarded $55 million  to an ovarian cancer victim who used Johnson & Johnson’s talc-based powders for nearly 40 years  for  feminine hygiene . In February, another Missouri trial  resulted in  an award of $72 million for the family of a woman who died from ovarian cancer  after using talc products for more than 30 years.

Talcum Powder Lawsuit Helpline

Women who were diagnosed with ovarian cancer are calling us for help on a daily basis. They all have one thing in common, They have been diagnosed with ovarian cancer and have used  talc-based products for feminine hygiene for years. They are angry and want to speak to a Talcum Powder lawyer.

The Talcum Powder Lawsuit Helpline is  A nationwide resource for women who have used Talcum powder for personal hygiene and have concerns. Many have a diagnosis of ovarian cancer.   The Network of Talcum Powder Lawsuit attorneys have years of experience  representing women whio have been injured by a wide variety of dangerous drugs and devices. They have represented these women in complex individual and class action lawsuits against pharmaceutical and medical device companies.

 

Talcum Powder- Ovarian Cancer Helpline

The Talcum Powder Lawsuit Helpline has Talcum Powder lawyers filing Talcum Powder lawsuits for women who have gotten ovarian cancer from Talcum Powder. The Talcum Powder Lawsuit Helpline continues to report any recent news regarding the lawsuits and research regarding ovarian cancer. Ovarian cancer is a serious and often fatal disease and we are constantly on the look out for new and important updates that may be of interest to our followers.

We found this article and thought it might be helpful to women. This article discusses some ways to make it easier to find out if you have or are at risk for ovarian cancer.

Testing the  DNA  of a woman should identify the most effective drugs and finds out if other family members are at risk.

Fewer than a third of patients are currently tested, but the team at the Institute of Cancer Research (ICR) in London made it easier for women and increased uptake to 100%.

Experts said the findings were an important step.

The focus of testing is a set of genetic mutations which run in families called BRCA – they cause 15% of the 7,100 ovarian cancers detected in the UK each year.

Knowing if the patient is in the 15% helps improve treatment as some chemotherapy drugs are more effective against tumours caused by BRCA mutations.

And cancer drugs such as PARP inhibitors work only in women with BRCA mutations.

A tumour that is positive for BRCA is also an early warning to other family members that they may be at risk of developing ovarian, breast or prostate cancers.

‘Excellent example’
Testing currently involves getting an appointment with a separate genetics team after being diagnosed by a cancer doctor. The average wait is 12-15 weeks, the researchers say, and only a minority of women go for it.

The ICR team used advances in genetics testing – which is getting faster and cheaper – to offer screening with the original cancer doctor.

Prof Nazneen Rahman, who led the trial, told the BBC News website: “It cuts off all that time on a waiting list and extra consultation. The feedback from patients has been overwhelmingly positive.”

The results of the trial, published in the journal Scientific Reports, showed all patients had screening and got their results in a quarter of the time. It also estimated the National Health Service would save £2.6m a year if it changed the way testing was offered.

Prof Rahman added: “There would be 283 fewer cancers and 77 fewer deaths a year – it really does save lives and money.

“It’s very unusual to get a win-win all round that allows us to help more people but doesn’t cost more.”

It is likely the approach would also work for other cancers, such as those in the breast.

Prof Paul Workman, the chief executive of ICR, said: “Twenty years ago the BRCA2 gene was identified at the ICR. This study is an excellent example of how science such as this can be turned into something very practical that can improve the patient care and save lives. We hope the new model for genetic testing will be rolled out across the NHS.”

Alexandra Holden, from the charity Target Ovarian Cancer, commented: “Any improved access to genetic testing for all women with ovarian cancer is an important step.

“It is essential that all women with ovarian cancer get genetic counseling, as we know from the women with ovarian cancer we support that there can be numerous, complex implications of a test, for all the family.”